Religare Enterprises completed the conversion of 35 lakh warrants into equity shares, allotting them to promoter group entity Puran Associates Private Limited. The company received ₹61.69 crore as the final tranche, bringing the total consideration to 100%. This increases the company's equity base.
Religare Enterprises Completes Promoter Warrant Conversion, Infuses ₹61.69 Crore
Religare Enterprises Ltd has allotted 35,00,000 equity shares to Puran Associates Private Limited, a promoter group entity, at an issue price of ₹235 per share. The company has received ₹61.69 crore as the final tranche for this conversion.
Reader Takeaway: Promoter capital infusion strengthens equity base; shares face SEBI lock-in restrictions.
What just happened
The Investment, Borrowing & Share Allotment Committee of Religare Enterprises approved the allotment of 35,00,000 equity shares. These shares were issued upon conversion of an equal number of warrants previously allotted to Puran Associates Private Limited.
Why this matters
This corporate action signifies a capital infusion by the promoter group, strengthening the company's equity base. The company has now received the full consideration for these shares, increasing its issued, subscribed, and paid-up equity share capital.
The backstory
The conversion follows the warrant allotment that occurred in September 2025. Puran Associates Private Limited has now paid the remaining 75% of the consideration, totaling ₹61.69 crore, to complete the conversion process.
What changes now
The company's equity share capital has increased from ₹341.23 crore to ₹344.73 crore. The total number of equity shares outstanding now stands at 34,47,33,742.
Risks to watch
The newly allotted equity shares are subject to regulatory lock-in periods as per SEBI ICDR Regulations. This means Puran Associates Private Limited cannot immediately sell these shares in the market, impacting their liquidity.
Peer comparison
No direct peer comparison is applicable for this specific event of warrant conversion by a promoter group entity.
Context metrics (time-bound)
- Shares Allotted: 35,00,000 equity shares.
- Consideration Received (Final Tranche): ₹61.69 crore.
- Issue Price: ₹235 per share.
- Total Capital Infusion: ₹61.69 crore.
- Allotment Date: August 06, 2026.
What to track next
Investors should monitor how Religare Enterprises utilizes the strengthened capital base to drive future business growth and operational performance.